GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » EV-to-EBITDA

Qlife Holding AB (OSTO:QLIFE) EV-to-EBITDA : -0.22 (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Qlife Holding AB's enterprise value is kr13.65 Mil. Qlife Holding AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was kr-60.80 Mil. Therefore, Qlife Holding AB's EV-to-EBITDA for today is -0.22.

The historical rank and industry rank for Qlife Holding AB's EV-to-EBITDA or its related term are showing as below:

OSTO:QLIFE' s EV-to-EBITDA Range Over the Past 10 Years
Min: -40.96   Med: -5.02   Max: -0.18
Current: -0.21

During the past 4 years, the highest EV-to-EBITDA of Qlife Holding AB was -0.18. The lowest was -40.96. And the median was -5.02.

OSTO:QLIFE's EV-to-EBITDA is ranked worse than
100% of 486 companies
in the Medical Devices & Instruments industry
Industry Median: 16.14 vs OSTO:QLIFE: -0.21

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Qlife Holding AB's stock price is kr0.0022. Qlife Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was kr-0.411. Therefore, Qlife Holding AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Qlife Holding AB EV-to-EBITDA Historical Data

The historical data trend for Qlife Holding AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB EV-to-EBITDA Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- -13.07 -12.75 -1.08

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.49 -1.08 -0.90 -0.32 -0.46

Competitive Comparison of Qlife Holding AB's EV-to-EBITDA

For the Medical Devices subindustry, Qlife Holding AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's EV-to-EBITDA falls into.



Qlife Holding AB EV-to-EBITDA Calculation

Qlife Holding AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=13.647/-60.802
=-0.22

Qlife Holding AB's current Enterprise Value is kr13.65 Mil.
Qlife Holding AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-60.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qlife Holding AB  (OSTO:QLIFE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Qlife Holding AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0022/-0.411
=At Loss

Qlife Holding AB's share price for today is kr0.0022.
Qlife Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.411.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Qlife Holding AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines